1-7 of 7
Margaret A. Shipp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo

Free
Yansheng Hao, Bjoern Chapuy, Stefano Monti, Heather H. Sun, Scott J. Rodig, Margaret A. Shipp
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (10): 2674–2683.
https://doi.org/10.1158/1078-0432.CCR-13-3007
Published: 14 May 2014
View articletitled, Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo
Open the PDF for Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo in another window
Includes: Supplementary data
Journal Articles

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

Free
Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang, Heather H. Sun, Margaretha G.M. Roemer, Mina L. Xu, Hongbo Yu, Christopher D.M. Fletcher, Gordon J. Freeman, Margaret A. Shipp, Scott J. Rodig
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3462–3473.
https://doi.org/10.1158/1078-0432.CCR-13-0855
Published: 30 June 2013
View articletitled, PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Open the PDF for PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies in another window
Includes: Supplementary data
Journal Articles

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

Free
Michael R. Green, Scott Rodig, Przemyslaw Juszczynski, Jing Ouyang, Papiya Sinha, Evan O'Donnell, Donna Neuberg, Margaret A. Shipp
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1611–1618.
https://doi.org/10.1158/1078-0432.CCR-11-1942
Published: 14 March 2012
View articletitled, Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Open the PDF for Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1

Free
Przemyslaw Juszczynski, Scott J. Rodig, Jing Ouyang, Evan O'Donnell, Kunihiko Takeyama, Wojciech Mlynarski, Katarzyna Mycko, Tomasz Szczepanski, Anna Gaworczyk, Andrei Krivtsov, Joerg Faber, Amit U. Sinha, Gabriel A. Rabinovich, Scott A. Armstrong, Jeffery L. Kutok, Margaret A. Shipp
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 2122–2130.
https://doi.org/10.1158/1078-0432.CCR-09-2765
Published: 31 March 2010
View articletitled, MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1
Open the PDF for MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1 in another window
Includes: Supplementary data
Journal Articles

AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

Free
Scott J. Rodig, Jing Ouyang, Przemyslaw Juszczynski, Treeve Currie, Kenneth Law, Donna S. Neuberg, Gabriel A. Rabinovich, Margaret A. Shipp, Jeffery L. Kutok
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3338–3344.
https://doi.org/10.1158/1078-0432.CCR-07-4709
Published: 02 June 2008
View articletitled, AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
Open the PDF for AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features in another window
Journal Articles

Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H)

Free
Scott J. Rodig, Jeremy S. Abramson, Geraldine S. Pinkus, Steven P. Treon, David M. Dorfman, Henry Y. Dong, Margaret A. Shipp, Jeffery L. Kutok
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7174–7179.
https://doi.org/10.1158/1078-0432.CCR-06-1275
Published: 04 December 2006
View articletitled, Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H)
Open the PDF for Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H) in another window
Journal Articles

FAS Death Domain Deletions and Cellular FADD-like Interleukin 1β Converting Enzyme Inhibitory Protein (Long) Overexpression: Alternative Mechanisms for Deregulating the Extrinsic Apoptotic Pathway in Diffuse Large B-Cell Lymphoma Subtypes

Free
Hidenobu Takahashi, Friedrich Feuerhake, Jeffery L. Kutok, Stefano Monti, Paola Dal Cin, Donna Neuberg, Jon C. Aster, Margaret A. Shipp
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3265–3271.
https://doi.org/10.1158/1078-0432.CCR-06-0076
Published: 01 June 2006
View articletitled, FAS Death Domain Deletions and Cellular FADD-like Interleukin 1β Converting Enzyme Inhibitory Protein (Long) Overexpression: Alternative Mechanisms for Deregulating the Extrinsic Apoptotic Pathway in Diffuse Large B-Cell Lymphoma Subtypes
Open the PDF for FAS Death Domain Deletions and Cellular FADD-like Interleukin 1β Converting Enzyme Inhibitory Protein (Long) Overexpression: Alternative Mechanisms for Deregulating the Extrinsic Apoptotic Pathway in Diffuse Large B-Cell Lymphoma Subtypes in another window